Asahi Paying $1.3bn For One-Product Veloxis
Increased US Presence The Main Goal
Diversified Japanese giant to launch tender for Danish transplant drug specialist as it looks to build US operations for health care business. Lundbeck and Novo Nordisk among investors that will see an exit.
